Literature DB >> 6753476

Osteitis and other complications caused by generalized BCG-itis. Experiences in Sweden.

M Böttiger, V Romanus, C de Verdier, G Boman.   

Abstract

In 1973 an increase in the number of osteitis caused by BCG vaccination in the neonatal period was observed in Sweden. A high incidence of this complication, i.e. 1 case per 3000 vaccinated newborn children continued until this vaccination was interrupted in 1975. In the years 1972 to 1980 a total of 90 cases were reported to the Adverse Drug Reaction Committee. Earlier retrospective studies had disclosed 36 cases born between 1949-1968 and an active search for unreported cases in the 1970s revealed an additional 26 cases. Of the total of 152 known cases in Sweden, 82 were boys and 70 girls. The mean incubation period was 14 months for boys and 23 for girls. Extremely long incubation periods were seen, i.e. 6 years in two children and 12 years in one. Eleven children had multiple osteitis lesions. The epiphyses of the long bones of the extremities were the most frequent sites of the affection (109 lesions). Only in 6 patients the spine, which is the common site of osteitis caused by tuberculosis, was affected. Relapses occurred in two patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6753476     DOI: 10.1111/j.1651-2227.1982.tb09454.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  11 in total

1.  Vertebral osteitis following BCG vaccination in a previously healthy child.

Authors:  L Moreno; F Gottrand; B Herbaux; C Savage; J P Farriaux
Journal:  Eur J Pediatr       Date:  1990-06       Impact factor: 3.183

2.  Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety.

Authors:  J B Milstien; J J Gibson
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

3.  Relationship of secretion pattern and MPB70 homology with osteoblast-specific factor 2 to osteitis following Mycobacterium bovis BCG vaccination.

Authors:  J C Ulstrup; S Jeansson; H G Wiker; M Harboe
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

4.  BCG vaccination as a cause of osteomyelitis and subcutaneous abscess.

Authors:  H Peltola; I Salmi; V Vahvanen; J Ahlqvist
Journal:  Arch Dis Child       Date:  1984-02       Impact factor: 3.791

5.  Mycobacterium bovis BCG causing vertebral osteomyelitis (Pott's disease) following intravesical BCG therapy.

Authors:  I S Aljada; J K Crane; N Corriere; D G Wagle; D Amsterdam
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

Review 6.  Indications and contraindications for vaccines used in the Expanded Programme on Immunization.

Authors:  A M Galazka; B A Lauer; R H Henderson; J Keja
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

Review 7.  Under-reporting of adverse drug reactions : a systematic review.

Authors:  Lorna Hazell; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

8.  Severe osteomyelitis as a complication of Tokyo-172 BCG vaccination.

Authors:  Hyo Jin Kwon; Bo Hyun Chung; Byung Min Choi; Kyung Un Park; Yun Kyung Kim
Journal:  J Korean Med Sci       Date:  2012-01-27       Impact factor: 2.153

9.  Mycobacterium bovis BCG-associated osteomyelitis/osteitis, Taiwan.

Authors:  Nan-Chang Chiu; Meng-Chin Lin; Wen-Li Lin; Shin-Yi Wang; Hsin Chi; Li-Min Huang; Ren-Bin Tang; Yhu-Chering Huang; Ching-Chuan Liu; Fu-Yuan Huang; Tzou-Yien Lin
Journal:  Emerg Infect Dis       Date:  2015-03       Impact factor: 6.883

10.  Mycobacterium bovis Osteitis Following Immunization with Bacille Calmette-Guérin (BCG) in Korea.

Authors:  Youn Young Choi; Mi Seon Han; Hoan Jong Lee; Ki Wook Yun; Chang Ho Shin; Won Joon Yoo; Tae-Joon Cho; Jung-Eun Cheon; Kyoung Un Park; Eun Hwa Choi
Journal:  J Korean Med Sci       Date:  2018-12-26       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.